ATE537822T1 - Antidepressivum - Google Patents

Antidepressivum

Info

Publication number
ATE537822T1
ATE537822T1 AT07829459T AT07829459T ATE537822T1 AT E537822 T1 ATE537822 T1 AT E537822T1 AT 07829459 T AT07829459 T AT 07829459T AT 07829459 T AT07829459 T AT 07829459T AT E537822 T1 ATE537822 T1 AT E537822T1
Authority
AT
Austria
Prior art keywords
antidepressant
derivative
amino acid
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
AT07829459T
Other languages
English (en)
Inventor
Masako Doi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE537822T1 publication Critical patent/ATE537822T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07829459T 2006-10-10 2007-10-10 Antidepressivum ATE537822T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006276611 2006-10-10
PCT/JP2007/069721 WO2008044691A1 (en) 2006-10-10 2007-10-10 Antidepressant agent

Publications (1)

Publication Number Publication Date
ATE537822T1 true ATE537822T1 (de) 2012-01-15

Family

ID=39282884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07829459T ATE537822T1 (de) 2006-10-10 2007-10-10 Antidepressivum

Country Status (10)

Country Link
US (1) US9060979B2 (de)
EP (1) EP2077111B1 (de)
JP (1) JP5266058B2 (de)
KR (1) KR20090077903A (de)
CN (1) CN101522185B (de)
AT (1) ATE537822T1 (de)
AU (1) AU2007305535A1 (de)
CA (1) CA2664054C (de)
TW (1) TWI397418B (de)
WO (1) WO2008044691A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635390B1 (en) * 2000-01-14 2009-12-22 Marctec, Llc Joint replacement component having a modular articulating surface
US7708741B1 (en) 2001-08-28 2010-05-04 Marctec, Llc Method of preparing bones for knee replacement surgery
SI3364958T1 (sl) 2015-10-23 2023-05-31 Navitor Pharmaceuticals, Inc. Modulatorji interakcije sestrina in gator2 ter njihova uporaba
WO2018047980A1 (ja) 2016-09-09 2018-03-15 味の素株式会社 認知症またはうつ状態の予防または改善用組成物
ES3040534T3 (en) * 2017-04-26 2025-11-03 Navitor Pharm Inc Modulator of sestrin-gator2 interaction for use in the treatment of treatment-resistant depression
MY208232A (en) * 2018-03-05 2025-04-25 Ajinomoto Kk Composition for enhancing cognitive function, composition for remedying anxiety symptoms, and composition for suppressing cerebral atrophy
CA3117336A1 (en) 2018-10-24 2020-04-30 Navitor Pharmaceuticals, Inc. Polymorphs of (s)-2-amino-5,5-difluoro-4,4-dimethylpentanoic acid for use in modulating mtorc1
IL292612A (en) 2019-11-01 2022-07-01 Navitor Pharm Inc Treatment methods using mtorc1 modulator
JP2023066490A (ja) * 2021-10-29 2023-05-16 花王株式会社 経口用顆粒組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02172915A (ja) 1988-12-23 1990-07-04 Ajinomoto Co Inc 脳細胞代謝改善組成物
JPH03275631A (ja) 1990-03-19 1991-12-06 Ajinomoto Co Inc 抗痴呆薬
JP3942207B2 (ja) 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
JPH08238148A (ja) * 1995-03-06 1996-09-17 Unicom:Kk 積木脚を備えた幼児用家具及びその構成部材
JP2000026289A (ja) 1998-07-01 2000-01-25 Crescendo Corporation:Kk 分岐鎖アミノ酸による筋肉痛・筋肉のこり、はりへの効果
JP2000026290A (ja) 1998-07-07 2000-01-25 Crescendo Corporation:Kk 分岐鎖アミノ酸による筋力維持
RU2151596C1 (ru) * 1999-03-10 2000-06-27 Казанский государственный университет им. В.И. Ульянова-Ленина Композиция аминокислот с микроэлементами и кальцием, обладающая противоопухолевой, антидепрессивной и противоаритмической активностью
WO2002034257A1 (fr) 2000-10-27 2002-05-02 Meiji Dairies Corporation Agents de recuperation ou de prevention de la fatigue dans le systeme nerveux central et aliments de recuperation ou de prevention associes
JP3341769B1 (ja) 2002-01-25 2002-11-05 味の素株式会社 分岐鎖アミノ酸含有チュアブル剤
JP3341770B1 (ja) 2002-01-30 2002-11-05 味の素株式会社 分岐鎖アミノ酸を含有するゼリー剤
JP4281281B2 (ja) 2002-01-30 2009-06-17 味の素株式会社 分岐鎖アミノ酸を含有するドライシロップ剤
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
GB0400031D0 (en) 2004-01-03 2004-02-04 Univ Sheffield Depression treatment
WO2005089774A1 (en) * 2004-03-18 2005-09-29 Tanabe Seiyaku Co., Ltd. D-ribose for improving depression-like symptoms
JP2005336176A (ja) * 2004-04-28 2005-12-08 Tanabe Seiyaku Co Ltd 肉体疲労改善剤
WO2006077954A1 (ja) * 2005-01-21 2006-07-27 Kyowa Hakko Kogyo Co., Ltd. 神経疾患治療剤

Also Published As

Publication number Publication date
KR20090077903A (ko) 2009-07-16
CN101522185B (zh) 2012-07-11
US9060979B2 (en) 2015-06-23
WO2008044691A1 (en) 2008-04-17
EP2077111A4 (de) 2010-03-24
EP2077111B1 (de) 2011-12-21
CA2664054A1 (en) 2008-04-17
EP2077111A1 (de) 2009-07-08
CN101522185A (zh) 2009-09-02
AU2007305535A1 (en) 2008-04-17
US20100105774A1 (en) 2010-04-29
JP5266058B2 (ja) 2013-08-21
JPWO2008044691A1 (ja) 2010-02-12
TW200820983A (en) 2008-05-16
CA2664054C (en) 2015-05-26
TWI397418B (zh) 2013-06-01

Similar Documents

Publication Publication Date Title
ATE537822T1 (de) Antidepressivum
NL301202I2 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
CY2020002I2 (el) Μυκητοκτονος συνθεση η οποια περιεχει ενα παραγωγο οξινου αμιδιου
HRP20120323T1 (en) Diarylhydantoin compounds
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
CY1119261T1 (el) Παραγωγα θειαζολιου
WO2007084728A3 (en) 2-imino-benzimidazoles
EP1950219A4 (de) Neue dihydropseudoerythromycinderivate
WO2007117465A3 (en) Indazole compounds
NO20091395L (no) Nye tiofenderivater
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
MXPA06000675A (es) Derivado de quinolona o sal del mismo.
NO20076347L (no) Nye regimer for orale monofasiske befruktningshindrene midler
EP1704856A4 (de) Proteininhibitor der hsp90-familie
DK1864665T3 (da) Immunsuppressivt middel indeholdende en heterocyklisk forbindelse som aktiv bestanddel
DE602005027540D1 (de) Feste formulierungen von ospemifen
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
UA100850C2 (ru) Средство для борьбы с паразитами на животных
MX2007003196A (es) Agente y alimento para evitar/mejorar el trastorno digestivo funcional.
TW200621160A (en) Anti-termite agent
EA200900640A1 (ru) Пиримидилметилсульфонамидные соединения
EP1900368A4 (de) Tablette mit einem kaum löslichen wirkstoff
EA201001125A1 (ru) Фармацевтические композиции, включающие n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамид
WO2009075250A1 (ja) 植物病害防除剤
GT200800296A (es) Derivados de ácido fenilacético